-+ 0.00%
-+ 0.00%
-+ 0.00%

Processa Pharmaceuticals Appoints Gregory J. Flesher Operations Chief

Benzinga·11/04/2026 13:06:07
Listen to the news

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for immunological and inflammatory diseases, today announced key leadership appointments to support the Company’s next phase of growth:

  • Gregory J. Flesher, Chief Operating Officer
  •